FIELD: medicine.
SUBSTANCE: substance of the invention involves production of drug product of human antianthrax intravenous immunoglobulin representing 5.0±0.5% protein fraction containing 100% IgG separated from blood plasma of donors tested for absence of human immunodeficiency virus and hepatitis antibodies and immunised with combined anthrax vaccine.
EFFECT: prolonged immunity maintenance.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| SERUM IMMUNOBIOLOGICAL PREPARATION FOR EMERGENCY ANTHRAX PREVENTION AND TREATMENT | 2008 |
|
RU2381037C1 |
| METHOD FOR TREATING GENERALIZED FORM OF ANTHRAX INFECTION | 2002 |
|
RU2214834C1 |
| ANTIVIRAL PREPARATION AND METHOD OF PREPARING IMMUNOGLOBULIN FOR PROPHYLAXIS AND TREATMENT OF PATIENT WITH VIRAL DISEASES | 1999 |
|
RU2144379C1 |
| STRAIN OF HYBRID CULTURED CELLS OF HOMO SAPIENS / MUS MUSCULUS 8D4E9-BA-LF-PRODUCER OF HUMAN MONOCLONAL ANTIBODIES AGAINST LETHAL FACTOR OF ANTHRAX AGENT | 2018 |
|
RU2699193C1 |
| METHOD FOR PRODUCING A STANDARD SAMPLE OF HUMAN IGG ANTIBODY CONTENT TO TICK-BORNE ENCEPHALITIS VIRUS | 2020 |
|
RU2735782C1 |
| PREPARATION CONTAINING ANTIBODY AGAINST BOLIVIAN HAEMORRAGIC FEVER FROM WHEY OF BLOOD OF HORSES, SOLUTION FOR INTRAMUSCULAR INTRODUCTION | 2007 |
|
RU2342952C1 |
| METHOD OF PRODUCING SMALLPOX IMMUNOGLOBULIN FROM HORSE BLOOD SERUM | 2020 |
|
RU2770425C2 |
| METHOD OF HUMAN ANTIDIPHTHERITIC IMMUNOGLOBULIN PREPARING | 1995 |
|
RU2150960C1 |
| METHOD OF PREPARING IMMUNOGLOBULIN PREPARATION FOR DIPHTHERIA PROPHYLAXIS AND THERAPY | 1994 |
|
RU2074725C1 |
| ANTIPNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION | 2018 |
|
RU2795769C1 |
